Pfizer: Crohn Disease trials
The registry lists 17 Crohn Disease studies with Pfizer as lead sponsor. 0 are open to participants now and 14 have results posted.
Phase 1 2Phase 2 10Phase 3 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisCompletedNCT05796245Results posted
- A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's DiseaseTerminatedNCT04173273Phase 2/3Results posted
- Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)CompletedNCT03884439Results posted
- Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel DiseaseCompletedNCT03801928Results posted
- Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's DiseaseCompletedNCT03395184Phase 2Results posted
- Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal PainCompletedNCT03155945Phase 2Results posted
- National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real LifeCompletedNCT02925338Results posted
- Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel DiseaseCompletedNCT02539368Results posted
- A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's DiseaseCompletedNCT01470599Phase 2Results posted
- The Safety And Efficacy Of Maintenance Therapy With CP-690,550CompletedNCT01393899Phase 2Results posted
- A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's DiseaseCompletedNCT01393626Phase 2Results posted
- B0151005 Open-Label Extension StudyCompletedNCT01345318Phase 2Results posted
- A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF TherapyCompletedNCT01287897Phase 2Results posted
- A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's DiseaseCompletedNCT00615199Phase 2Results posted
- Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy PeopleTerminatedNCT01162889Phase 1
- Study Evaluating ERB-041 in Active Crohn's DiseaseCompletedNCT00245947Phase 1
- Study Evaluating rhIL-11 in Active Crohn's DiseaseCompletedNCT00040521Phase 2